SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences to launch Botulinum Neurotoxin

19 Jul 2019 Evaluate

Gufic Biosciences is going to launch Botulinum Neurotoxin in India in collaboration with USA based Company Prime Bio, Inc. The company has received regulatory approval to manufacture and market Botulinum Neurotoxin.

The company is an indigenous manufacturing company to launch such project in India with a robust and inherent world class infrastructure which will help the company to bring the cost effective option of this toxin to India and also expand them to Middle East, East and Southeast Asia.

Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.

Gufic Biosciences Share Price

301.30 -1.35 (-0.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×